Sample results
Prostate cancer metastasis is the spread of prostate cancer cells from the prostate gland to distant organs such as bones, lymph nodes, or other tissues. It occurs when cancer cells break away from the primary tumor and travel through the bloodstream or lymphatic system to establish new tumors in other parts of the body. The Prostate-Specific Antigen (PSA) Ultrasensitive test is the most important blood test for detecting early signs of metastasis after prostate removal surgery.
Prostate cancer metastasis is caused by malignant cells breaking away from the primary prostate tumor and spreading through the bloodstream or lymphatic system to distant sites. The cancer cells most commonly travel to bones (especially the spine, pelvis, and ribs), regional lymph nodes, liver, and lungs. Advanced prostate cancer cells develop the ability to invade surrounding tissues, enter blood vessels, survive in circulation, and establish new tumors in distant organs, a process driven by genetic mutations and changes in cell behavior that allow them to evade normal growth controls.
The Prostate-Specific Antigen (PSA) Ultrasensitive test is the most important blood test for prostate cancer metastasis because it can detect extremely low levels of PSA in men who have undergone prostatectomy. Since the prostate normally produces PSA, any detectable or rising PSA levels after prostate removal surgery indicates that cancer cells are still present and potentially spreading to other parts of the body. This ultrasensitive test can detect PSA at levels as low as 0.01 ng/mL, allowing for much earlier detection of biochemical recurrence and potential metastasis compared to standard PSA tests, which gives you and your doctor critical time to adjust treatment strategies.
You should get tested if you have had a prostatectomy and are monitoring for cancer recurrence, if you experience new bone pain or fractures without injury, if you notice unexplained weight loss or fatigue, or if your oncologist recommends regular PSA monitoring as part of your follow-up care. Men with high-risk prostate cancer features at initial diagnosis should have more frequent testing, typically every 3-6 months for the first few years after treatment. Any new symptoms such as difficulty walking, back pain, or urinary problems after prostate cancer treatment warrant immediate testing.
What this means
Your testosterone levels are slightly below the optimal range. While this is not necessarily cause for concern, it may contribute to occasional fatigue, reduced motivation, or lower muscle mass over time.
Recommended actions
Increase resistance or strength training
Prioritize 7–8 hours of quality sleep per night, try to reduce stress
Include more zinc- and magnesium-rich foods (like shellfish, beef, pumpkin seeds, spinach)
Consider retesting in 3–6 months
Not overhyped or overpriced. Just comprehensive blood testing made simple and for everyone.
Sample results
Your 24/7 Lab Guide
Quick questions: